36 related articles for article (PubMed ID: 11681849)
1. Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.
Sayed NH; Fathy N; Kortam MA; Rabie MA; Mohamed AF; Kamel AS
Neurotherapeutics; 2020 Jan; 17(1):252-268. PubMed ID: 31728850
[TBL] [Abstract][Full Text] [Related]
2. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease.
Palfi S; Ferrante RJ; Brouillet E; Beal MF; Dolan R; Guyot MC; Peschanski M; Hantraye P
J Neurosci; 1996 May; 16(9):3019-25. PubMed ID: 8622131
[TBL] [Abstract][Full Text] [Related]
3. Deep behavioural phenotyping of the Q175 Huntington disease mouse model: effects of age, sex, and weight.
Koch ET; Cheng J; Ramandi D; Sepers MD; Hsu A; Fong T; Murphy TH; Yttri E; Raymond LA
BMC Biol; 2024 May; 22(1):121. PubMed ID: 38783261
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the Cholinergic Parameters and Glial Cells in Learning Delay Induced by Glutaric Acid: Protection by N-Acetylcysteine.
Rodrigues FS; de Zorzi VN; Funghetto MP; Haupental F; Cardoso AS; Marchesan S; Cardoso AM; Schinger MRC; Machado AK; da Cruz IBM; Duarte MMMF; Xavier LL; Furian AF; Oliveira MS; Santos ARS; Royes LFF; Fighera MR
Mol Neurobiol; 2019 Jul; 56(7):4945-4959. PubMed ID: 30421167
[TBL] [Abstract][Full Text] [Related]
5. The Allure of High-Risk Rewards in Huntington's disease.
van Wouwe NC; Kanoff KE; Claassen DO; Richard Ridderinkhof K; Hedera P; Harrison MB; Wylie SA
J Int Neuropsychol Soc; 2016 Apr; 22(4):426-35. PubMed ID: 26708084
[TBL] [Abstract][Full Text] [Related]
6. Early-life exposure to noise reduces mPFC astrocyte numbers and T-maze alternation/discrimination task performance in adult male rats.
Ruvalcaba-Delgadillo Y; Luquín S; Ramos-Zúñiga R; Feria-Velasco A; González-Castañeda RE; Pérez-Vega MI; Jáuregui-Huerta F; García-Estrada J
Noise Health; 2015; 17(77):216-26. PubMed ID: 26168952
[TBL] [Abstract][Full Text] [Related]
7. Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.
Fink KD; Crane AT; Lévêque X; Dues DJ; Huffman LD; Moore AC; Story DT; Dejonge RE; Antcliff A; Starski PA; Lu M; Lescaudron L; Rossignol J; Dunbar GL
Stem Cells Transl Med; 2014 May; 3(5):620-31. PubMed ID: 24657963
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms.
Kumar P; Kumar A
Psychopharmacology (Berl); 2009 Dec; 207(2):257-70. PubMed ID: 19763544
[TBL] [Abstract][Full Text] [Related]
9. No spatial memory deficit exists in Kunming mice that recently recovered from motor defects following 3-nitropropionic acid intoxication.
Li XM; Zhu BG; Ni JB; Cao CY; Zhang JP; Zhao XD; Zhu RS
Neurosci Bull; 2009 Apr; 25(2):87-93. PubMed ID: 19290027
[TBL] [Abstract][Full Text] [Related]
10. Behavioral alterations in Lewis rats following two-day continuous 3-nitropropionic acid administration.
Newcomb JD; Brown WD; Rodriguez AI; Garbuzova-Davis S; Saporta S; Sanberg PR; Willing AE
Neurotox Res; 2005 Nov; 8(3-4):259-66. PubMed ID: 16371320
[TBL] [Abstract][Full Text] [Related]
11. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Van Raamsdonk JM; Pearson J; Slow EJ; Hossain SM; Leavitt BR; Hayden MR
J Neurosci; 2005 Apr; 25(16):4169-80. PubMed ID: 15843620
[TBL] [Abstract][Full Text] [Related]
12. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation.
Faure A; Haberland U; Condé F; El Massioui N
J Neurosci; 2005 Mar; 25(11):2771-80. PubMed ID: 15772337
[TBL] [Abstract][Full Text] [Related]
13. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists.
Blum D; Galas MC; Pintor A; Brouillet E; Ledent C; Muller CE; Bantubungi K; Galluzzo M; Gall D; Cuvelier L; Rolland AS; Popoli P; Schiffmann SN
J Neurosci; 2003 Jun; 23(12):5361-9. PubMed ID: 12832562
[TBL] [Abstract][Full Text] [Related]
14. The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.
Blum D; Gall D; Galas MC; d'Alcantara P; Bantubungi K; Schiffmann SN
J Neurosci; 2002 Oct; 22(20):9122-33. PubMed ID: 12388620
[TBL] [Abstract][Full Text] [Related]
15. Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.
El Massioui N; Ouary S; Chéruel F; Hantraye P; Brouillet E
Exp Neurol; 2001 Nov; 172(1):172-81. PubMed ID: 11681849
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
17. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
[TBL] [Abstract][Full Text] [Related]
18. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.
Joel D; Ayalon L; Tarrasch R; Weiner I
Mov Disord; 2003 Dec; 18(12):1499-507. PubMed ID: 14673887
[TBL] [Abstract][Full Text] [Related]
19. Lead-induced changes in learning: evidence for behavioral mechanisms from experimental animal studies.
Rice DC
Neurotoxicology; 1993; 14(2-3):167-78. PubMed ID: 8247391
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
